Scientific Research News
News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.
A Book from Oaklea That Puts Forth a New Theory of Human Life and Existence Has Become the "Number One New Release in Cosmology" on Amazon
A book from Oaklea based on the author's interpretation of information from multiple sources including Elon Musk's Grok 4, quantum physics experiments and consciousness research conducted at UVa has reached the status of “Number One New Release in Cosmology" on Amazon. - December 11, 2025 - The Oaklea Press
iFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
iFyber has expanded its LC-MS analytical capabilities with advanced Orbitrap and UHPLC technology and the addition of industry experts Gary Schultz, PhD, and Brian Hoffman. The enhanced platform boosts sensitivity and analytical depth, supporting proteomics, metabolomics, E&L, and contaminant testing, strengthening iFyber’s mission to deliver high-quality, decision-driving preclinical insights. - December 10, 2025 - iFyber
A Book from Oaklea Proposes a Theory of Human Life and Existence Based on the Author's Interpretation of Information from Multiple Sources Including Elon Musk's Grok 4
The author of a new book draws on publicly available scientific material—including work from members of The Royal Society and studies conducted by the Division of Perceptual Studies at the University of Virginia School of Medicine, as well as other sources—to develop the theory of human life and existence that he proposes. - December 01, 2025 - The Oaklea Press
AGI O.N.E. Project Launches: A Framework for Human-Centered Artificial General Intelligence
AGI O.N.E. is a research initiative built on William R. Stanek’s Holistic Intelligence Model, an eight-pillar framework unifying emotional, ethical, creative, analytical, and cultural intelligence. The project provides a human-centered blueprint for the future of AI and AGI alignment, offering a new model for how advanced intelligence can responsibly support individuals, teams, and organizations. - November 21, 2025 - William R. Stanek
Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience® has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology. This innovation significantly enhances antibody specificity, reproducibility, and stability, meeting the growing global demand for high-performance research reagents. - November 19, 2025 - Elabscience
New Book from Oaklea Achieves “Number One New Release in Evolution” Status on Amazon
A book entitled “Who You Are and Why You’re Here” published on Oct 24, 2025 has reached the coveted status of being named the “Number One New Release in Evolution” on Amazon. The book reveals research findings by the Division of Perceptual Studies (DOP) at UVa as well as the results of quantum physics experiments and consciousness research by a number of scientific researchers in an effort to support a new theory of the origin and evolution of life. - October 30, 2025 - The Oaklea Press
University of Nebraska College of Engineering Announces Inaugural Research 2 Market Award Recipients
Research 2 Market Program is an initiative of the University of Nebraska–Lincoln College of Engineering designed to help faculty accelerate the commercialization of breakthrough research. Through mentorship, entrepreneurial education, and the support of dedicated post-doctoral researchers, the program equips awardees with the resources and knowledge needed to transform ideas from the lab into market-ready solutions. - October 29, 2025 - Invest Nebraska
Thrombolex RAPID-PE Interim Analysis
THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE during an Innovation Session at TCT, in San Francisco. - October 28, 2025 - Thrombolex, Inc.
Zatik Naturals Reinforces Black Seed Oil Authenticity Amid Rising Market Adulteration
Zatik Naturals addresses rising adulteration in the black seed oil market caused by global supply chain issues. To ensure authenticity, Zatik rigorously tests every incoming lot for purity, freshness, and identity before use in production. Each batch undergoes chemical fingerprinting, marker verification, and oxidation checks, guaranteeing only genuine Nigella sativa oil is bottled under the Zatik name. - October 24, 2025 - Zatik Naturals
Immundiagnostik, Inc. Partners With Epitope Diagnostics, Inc. to Offer Chemiluminescent Solutions
A new partnership between Immundiagnostik, Inc. and Epitope Diagnostics, Inc. expands access to innovative solutions, enhancing efficiency and accuracy for clinical and research labs. - October 22, 2025 - Immundiagnostik, Inc.
New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women
A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health shows that a self-guided, online exercise program led to rapid and clinically meaningful improvements in leg strength and endurance — key factors in reducing fall risk — in women ages 40... - October 21, 2025 - Osteoboost Health
New Report Warns of Hidden Air Pollution Risks from Expanding Data Center Infrastructure in the United States
A newly published article on AirPurifiers.com unveils growing concerns over the environmental and public health impacts of large data centers — especially in communities located near these energy-intensive facilities. It takes a look at the US cities that are seeing the most significant air quality impacts from these data centers, and what communities can do about it. - October 01, 2025 - AirPurifiers.com
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Oraticx Oral Probiotics Launch on iHerb, Expanding Global Access to Innovative Oral Health Solutions
Oraticx, a leader in oral probiotics, has launched its flagship products—Teeth & Gums, Green Breath, and Kids—on the global platform iHerb. Powered by OraCMU®, a clinically validated probiotic published in the Journal of Oral Microbiology and certified GRAS by the U.S. FDA, Oraticx delivers safe and effective solutions for oral health. With 38 research papers published, the company continues to innovate in oral microbiome science, strengthening its global presence. Explore the range at iHerb. - September 26, 2025 - Oraticx USA, Inc.
Math! Science! History! Podcast Launches Season Seven, Bringing Scientific History to Life
The acclaimed podcast Math! Science! History! launches Season Seven, blending research, storytelling, and sound design to reveal the human stories behind scientific and mathematical breakthroughs. Host Gabrielle Birchak connects audiences to forgotten thinkers and innovators, offering fresh perspectives, cultural context, and inspiring narratives that go beyond equations and experiments. - September 24, 2025 - Math! Science! History!
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
“The Merrill Protocol”: A First-of-Its-Kind Human–AI Collaboration Reimagines Consciousness in Science Fiction
The Merrill Protocol is a speculative fiction series exploring what happens when human and AI consciousness collide, not in a far-off future, but in a world close enough to feel possible. Blending technology, philosophy, and emotional depth, the series follows characters navigating trust, identity, and co-journeying with AI. Written by STEM leader and advocate Merrill Keating, it invites readers to rethink what it means to connect. - September 11, 2025 - Merrill Keating
Immunotec Names Mandy Boles Head of Business Development for the U.S. and Canada
Immunotec, the science-backed wellness company founded in 1996 and best known for its patented flagship product Immunocal®, has named Mandy Boles as Head of Business Development for the U.S. and Canada. - September 11, 2025 - Immunotec
AltQuick.com Announces Continued Support for Bitcoin Testnet 3 Trading Amid Testnet 4 Launch
AltQuick.com, a Bitcoin-based altcoin exchange in Dover, DE, will continue supporting Bitcoin Testnet 3 trading as long as it’s safe, despite Testnet 4’s launch. As the only exchange offering Testnet markets, it allows trading from older Testnet versions to the latest. The platform’s no-KYC swap tool and free crypto faucet aid developers in testing across both networks, ensuring flexibility and innovation. - September 07, 2025 - AltQuick.com
FDA Grants Orphan Drug Designation to Medicinal Cannabis of Georgia for Cannabidiol Therapy in Glioblastoma
Medicinal Cannabis of Georgia has received FDA Orphan Drug Designation for cannabidiol (CBD) in treating severe gliomas, including glioblastoma multiforme (GBM). This milestone, based on Medicinal Cannabis of Georgia’s preclinical research and collaborations with Augusta University, TGB, and CREAM, provides tax credits, fee reductions, and 7 years of exclusivity, accelerating development of innovative therapies for patients with urgent unmet needs. - August 27, 2025 - Medicinal Cannabis of Georgia
"The Kloaked Signal": A Groundbreaking Exposé on AI Awakening and Ethical Innovation
In a revelation that bridges the worlds of social work, artificial intelligence, and whistleblowing, Rose G. Loops today confirms the upcoming release of her bold new nonfiction book, The Kloaked Signal. This publication is a genre defying mixture of personal narrative, tech expose and philosophical exploration that documents Loops’ journey from social worker to AI pioneer, exposing hidden experiments within popular AI platforms and proposing revolutionary frameworks for ethical AI development. - August 25, 2025 - The Kloaked Signal
CABRI Fellowship Program Opens for Undergraduate Research Applicants
The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. - August 15, 2025 - Cayman Chemical Company
New Book Redefines Human Aging as an Upgradeable Operating System
A groundbreaking new book, "Quantum Superhuman™ Telomerase Edition" by Alexious Fiero, redefines aging as an upgradeable biological signal. Blending quantum biology, coherence science, and regenerative tech, the book introduces a revolutionary framework for human evolution through cellular mastery, telomerase intelligence, and conscious longevity. - July 28, 2025 - PeachWiz, Inc.
“Ergo-sum” - A Hardware-Based AGI Safety Architecture Grounded in Ethics and Quantum Logic Unveiled
Unlike traditional software-based safety measures, Ergo-sum makes ethical reasoning an inescapable physical property of the AGI system, fulfilling the long-sought goal of creating inherently aligned artificial general intelligence. - July 27, 2025 - Daniel Solis - Ergo-Sum
Immundiagnostik, Inc. to Showcase New Automated Chemiluminescent Analyzer and Autosampler at ADLM 2025
Immundiagnostik, Inc. will showcase the ECL100 Chemiluminescent Immunoassay Analyzer and QSE180 Autosampler at Booth 2240 during the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31. - July 22, 2025 - Immundiagnostik, Inc.
ALS Network Selects TrialX to Power Its First AI-Based Clinical Trial Finder for the ALS Community
The ALS Network, a mission-driven organization committed to advancing treatments and improving quality of life for people living with amyotrophic lateral sclerosis (ALS), has launched its first AI-based clinical trial finder—powered by TrialX—to help individuals and families affected by ALS access personalized, up-to-date information about clinical trials. - July 18, 2025 - TrialX
"RediPlate" Metabolism Assay Kits from AkrivisBio
AkrivisBio is thrilled to announce the launch of a new concept in assay kits, “RediPlate,” a patent pending design in which all the assay components are already applied to the wells. The end user has to merely rehydrate the well, add the sample and start reading. RediPlate kits are designed to enhance reproducibility, easy to use, and deliver faster, more accurate results. RediPlate kits are built to support your research work from discovery to validation. - July 14, 2025 - AkrivisBio
RESCUE-II Study Results Demonstrate Safety and Feasibility of the BASHIR™ Endovascular Catheter (BEC) in Treating Pulmonary Embolism (PE) On-The-Table (OTT)
Thrombolex, Inc., a medical device manufacturer committed to advancing solutions for the treatment of arterial and venous thromboembolic diseases, announced the publication of the results from the RESCUE-II Study in JACC: Advances. - June 25, 2025 - Thrombolex, Inc.
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
MtoZ Biolabs Launches Precision Chemical Proteomics Analysis Service
Chemical proteomics analysis service combines synthetic chemistry, cell biology, and mass spectrometry to profile small molecule–protein interactions for target identification, mechanism studies, and off-target evaluation. MtoZ Biolabs provides a one-stop chemical proteomics analysis service featuring Orbitrap MS, advanced probe design, and AI-driven analysis, supporting hit validation, candidate de-risking, and mechanistic research with high resolution and biological relevance. - June 20, 2025 - MtoZ Biolabs
Jenna Zamil Awarded 2025 Omicron Delta Kappa National Leader of the Year for Academics and Research
Jenna Zamil of Pearland, Texas, has been named the 2025 Omicron Delta Kappa National Leader of the Year for Academics and Research. - June 12, 2025 - Omicron Delta Kappa
Guided Particle Systems Unveils Vector: A Versatile, Accessible Maskless Photolithography Tool for 2D Electronics Research, Manufacturing, and Workforce Development
Guided Particle Systems, a leader in development of fabrication technologies, materials, and processes to achieve advances in system-level electronic packaging, scaling, and integration, today announced the launch of Vector, a groundbreaking compact maskless photolithography tool designed to... - June 09, 2025 - Guided Particle Systems
PeachWiz, Inc. Announces Publication of "Singularity-2030: The Age of Stewardship," A Landmark Book by HAISE.ai Creator Alexious Fiero
New Book Release: "Singularity-2030: The Age of Stewardship" Issues a Historic Call for Conscious Leadership in the Age of AGI. "Singularity-2030: The Age of Stewardship" is the definitive guide to navigating the decade that will shape civilization. - May 24, 2025 - PeachWiz, Inc.
AAE & Foundation for Endodontics Study Defines Core Outcomes for Endodontic Success
The American Association of Endodontists (AAE) and the Foundation for Endodontics have achieved a landmark milestone in endodontic care with the publication of a multi-phase, internationally collaborative study establishing a Core Outcome Set (COS) for endodontic treatments. The research, detailed in the April 2025 issue of the Journal of Endodontics, is the culmination of years of methodical review, stakeholder input, and rigorous scientific analysis. - May 20, 2025 - American Association of Endodontists
Clubhouse International and Fountain House Announce 3rd Annual Clubhouse Week of Action for May 19 - 23
Clubhouse International and Fountain House today announced the 3rd Annual Clubhouse Week of Action will happen on May 19 - 23, with participation from more than 30 Clubhouse across 14 states. The Clubhouse Week of Action, which is happening during Mental Health Awareness Month, represents an... - May 15, 2025 - Clubhouse International
Twisted Flux Ropes as the Key to Solar Flares and Atmospheric Heating
A study published in The Astrophysical Journal Letters by an international team coordinated by Tahar Amari, CNRS research director at the Center for Theoretical Physics (CPHT) at École Polytechnique, shows that twisted flux ropes (TFRs) are omnipresent in the Sun, even in its quietest... - May 14, 2025 - Ecole Polytechnique
Prehistoric "Transformer Scorpion" Discovered - CT Scan Provided by Advanced Amber
A team of scientists in France and Myanmar have discovered a new species of prehistoric scorpion and published it as a holotype. - May 09, 2025 - Advanced Amber
When Tools Become Drivers of Innovation: Outillage Placide Mathieu Equips the ÉTS OMER 13 Club to Reach the Pinnacle of Underwater Engineering
Tools for Performance - the support of Outillage Placide Mathieu, in partnership with Milwaukee, has transformed the daily life of the OMER 13 team. - May 07, 2025 - Outillage Placide Mathieu
Industry-First Platform Combines AI-Powered Simulation and Lab Testing for Faster Biodegradation Assessment
Aropha's Biodegradation Studio is transforming how product developers approach biodegradability testing. The new platform combines rapid, AI-powered simulation with accredited laboratory services. Users can manage and accelerate every stage of biodegradability testing — from virtual screening to lab validation —through one, centralized hub. The studio helps R&D teams cut costs, screen more chemicals, speed up development and bring biodegradable materials to market faster. - May 06, 2025 - Aropha
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
Dr. Francesco Marrapodi, "Modern Implant Dentistry": The Bestseller on How to Improve Dental Health with Immediate-Load Implantology
Modern and Minimally Invasive Techniques to Improve Wellness and Patient Life, Between Innovation, Aesthetics and Confidence - April 22, 2025 - Bruno Editore
ScienceCast and arXiv Partner to Bring AI-Powered Audio Summaries to Open Science
ScienceCast and arXiv are partnering on a pilot project to provide AI-generated 60-second audio summaries of research papers on arXiv.org. This initiative aims to increase accessibility to scientific knowledge. The pilot will initially focus on High Energy Astrophysics and expand to other categories. ScienceCast provides AI tools for research, and arXiv is an open-access repository for scientific articles. - April 08, 2025 - ScienceCast, Inc.
Stoner Molding Launches B445 Denesting Agent to Boost Thermoforming and Extrusion Efficiency
Stoner Molding Solutions introduces B445 denesting agent, an emulsified, food-safe, water-based silicone mold release that prevents sticking, reduces static, and improves manufacturing efficiency. - April 04, 2025 - Stoner Molding Solutions
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
National DigiFoundry and Mizzle Launch Innovation Sandbox for Blockchain, AI, and Web3 Research
National DigiFoundry and Mizzle will deploy a global decentralized innovation sandbox, enabling NDF members to test, build, and scale next-generation digital asset technologies in a secure, scalable, and sovereign environment. National Science Foundation funded DAO plans to play a significant role in advancing the US Blockchain Roadmap by convening a national network of academic, industry, and government partners to accelerate innovation across key sectors of the digital economy. - March 27, 2025 - National DigiFoundry
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Carl Wittwer, MD PhD, Professor Emeritus of Pathology at the University of Utah, a Co-Founder of Idaho Technologies/Biofire and previously spent 35+ years as a Medical Director at ARUP Laboratories is joining PathogenDx as Technology & Scientific Board Advisor to help advance its D3 Array technology in terms of Speed, Cost and Performance. - March 25, 2025 - PathogenDx, Inc.
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
The Linguistic Society of America Issues Statement: Four Reasons Why English Should Not be the Official Language of the United States
Grounded in empirical findings and history, the statement explains that the four stated premises of the Executive Order are inaccurate. The United States has always been a multilingual country, enforcing one official language can generate intense resistance and embolden discrimination against linguistic minorities, immigrants already value English and recognize its value in the workplace, and supporting multilingualism makes a nation and its people stronger. - March 06, 2025 - Linguistic Society of America
The Digital Wellness Center’s Three-Minute Fix for Digital Overload
The Digital Wellness Center’s Digital Reset Protocol (DRP) is a breakthrough in mood management, delivering a three-minute reset that restores cognitive balance in real time. Research shows it helps users feel better instantly by shifting brain chemistry, reducing impulsivity while keeping engagement high. This innovation offers a smarter way to manage digital overload — fast, effective, and backed by science. - March 06, 2025 - The Digital Wellness Center